N-[5-[3-(4-thiophen-3-yl-1H-indol-2-yl)-1H-pyrazolo[3,4-c]pyridin-5-yl]-3-pyridinyl]butanamide
C27H22N6OS — CID 137113851
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[5-[3-(4-thiophen-3-yl-1H-indol-2-yl)-1H-pyrazolo[3,4-c]pyridin-5-yl]-3-pyridinyl]butanamide
N-[5-[3-(4-thiophen-3-yl-1H-indol-2-yl)-1H-pyrazolo[3,4-c]pyridin-5-yl]-3-pyridinyl]butanamide (PubChem CID 137113851) has the molecular formula C27H22N6OS and a molecular weight of 478.58 g/mol. Its IUPAC name is N-[5-[3-(4-thiophen-3-yl-1H-indol-2-yl)-1H-pyrazolo[3,4-c]pyridin-5-yl]-3-pyridinyl]butanamide.
Molecular Properties
| Compound Name | N-[5-[3-(4-thiophen-3-yl-1H-indol-2-yl)-1H-pyrazolo[3,4-c]pyridin-5-yl]-3-pyridinyl]butanamide |
|---|---|
| PubChem CID | 137113851 |
| Molecular Formula | C27H22N6OS |
| Molecular Weight | 478.58 g/mol |
| Exact Mass | 478.16 |
| IUPAC Name | N-[5-[3-(4-thiophen-3-yl-1H-indol-2-yl)-1H-pyrazolo[3,4-c]pyridin-5-yl]-3-pyridinyl]butanamide |
| SMILES | CCCC(=O)Nc1cncc(-c2cc3c(-c4cc5c(-c6ccsc6)cccc5[nH]4)n[nH]c3cn2)c1 |
| InChI | InChI=1S/C27H22N6OS/c1-2-4-26(34)30-18-9-17(12-28-13-18)23-11-21-25(14-29-23)32-33-27(21)24-10-20-19(16-7-8-35-15-16)5-3-6-22(20)31-24/h3,5-15,31H,2,4H2,1H3,(H,30,34)(H,32,33) |
| InChIKey | RQEMRERMUFQHSZ-UHFFFAOYSA-N |
| XLogP | 6.64 |
| TPSA | 99.35 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 478.58 |
| LogP ≤ 5 | 6.64 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 137113851 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.